BIOQUAL, Inc.
BIOQ
$37.51
-$0.19-0.50%
OTC PK
| 11/30/2025 | 08/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 11.40% | -15.54% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 11.40% | -15.54% | |||
| Cost of Revenue | 11.07% | 60.71% | |||
| Gross Profit | 14.87% | -85.60% | |||
| SG&A Expenses | 1.56% | -77.51% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 9.79% | -11.99% | |||
| Operating Income | 20.91% | -338.92% | |||
| Income Before Tax | 44.82% | -1,405.70% | |||
| Income Tax Expenses | 44.82% | -176.91% | |||
| Earnings from Continuing Operations | 44.82% | -157.29% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 44.82% | -157.29% | |||
| EBIT | 20.91% | -338.92% | |||
| EBITDA | 229.89% | -89.39% | |||
| EPS Basic | 44.82% | -157.35% | |||
| Normalized Basic EPS | 44.83% | -1,404.35% | |||
| EPS Diluted | 45.18% | -154.55% | |||
| Normalized Diluted EPS | 44.83% | -1,404.35% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||